Comex 信息 以色列 30 - pharmaceutical products 3002 - 人体或动物制品
圖形 - 以色列 - 進口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 全年 FOB USD
-and-similar-products/WD-IL/1064/1/1/Fob/DepartureCountry-Date/All-Israel-Imports-1064-Year.png)
圖形 - 以色列 - 進口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 全年 FOB USD
-and-similar-products/WD-IL/1064/1/1/Fob/DepartureCountry-Date/All-Israel-Imports-1064-Year.png)
表 - 以色列 - 進口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 全年 FOB USD
|
Date
Export Countries
|
2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 美國 | 264.342.000 | 291.527.000 | 234.718.000 | 247.581.000 | 226.287.000 | 103.022.000 |
| 德國 | 260.981.000 | 217.620.000 | 222.496.000 | 187.956.000 | 191.172.000 | 58.779.000 |
| 瑞士 | 154.639.000 | 164.702.000 | 177.509.000 | 214.948.000 | 216.323.000 | 69.844.000 |
| 愛爾蘭 | 157.487.000 | 174.306.000 | 164.613.000 | 176.312.000 | 167.029.000 | 53.256.000 |
| 比利時 | 106.783.000 | 428.635.000 | 157.806.000 | 47.253.000 | 64.545.000 | 12.600.000 |
| 西班牙 | 17.855.000 | 80.678.000 | 85.216.000 | 121.884.000 | 95.459.000 | 3.034.000 |
| 法國 | 48.316.000 | 70.762.000 | 48.035.000 | 64.318.000 | 74.003.000 | 32.136.000 |
| 荷蘭 | 24.570.000 | 28.223.000 | 30.211.000 | 59.344.000 | 65.779.000 | 44.482.000 |
| 義大利 | 23.471.000 | 34.779.000 | 30.615.000 | 52.141.000 | 48.410.000 | 22.415.000 |
| 英國 | 28.961.000 | 24.771.000 | 29.839.000 | 42.388.000 | 46.470.000 | 14.073.000 |
| Others | 51.248.000 | 110.541.000 | 195.754.000 | 106.918.000 | 118.843.000 | 45.320.000 |
| Total | 1,138,653,000 | 1,626,544,000 | 1,376,812,000 | 1,321,043,000 | 1,314,320,000 | 458,961,000 |
圖形 - 以色列 - 進口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 每月 FOB USD
-and-similar-products/WD-IL/1064/1/4/Fob/DepartureCountry-Date/All-Israel-Imports-1064-Month.png)
圖形 - 以色列 - 進口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 每月 FOB USD
-and-similar-products/WD-IL/1064/1/4/Fob/DepartureCountry-Date/All-Israel-Imports-1064-Month.png)
表 - 以色列 - 進口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 每月 FOB USD
|
Date
Export Countries
|
11 - 2024 | 12 - 2024 | 01 - 2025 | 02 - 2025 | 03 - 2025 | 04 - 2025 |
|---|---|---|---|---|---|---|
| 美國 | 19.743.000 | 10.439.000 | 26.785.000 | 28.388.000 | 30.119.000 | 17.730.000 |
| 瑞士 | 20.000.000 | 13.647.000 | 12.748.000 | 16.837.000 | 30.581.000 | 9.678.000 |
| 德國 | 23.354.000 | 8.540.000 | 13.826.000 | 17.277.000 | 17.277.000 | 10.399.000 |
| 愛爾蘭 | 24.337.000 | 2.700.000 | 28.126.000 | 6.090.000 | 5.408.000 | 13.632.000 |
| 荷蘭 | 3.556.000 | 2.210.000 | 1.533.000 | 2.363.000 | 21.984.000 | 18.602.000 |
| 法國 | 1.806.000 | 14.072.000 | 4.913.000 | 9.203.000 | 13.824.000 | 4.196.000 |
| 義大利 | 6.856.000 | 3.828.000 | 3.256.000 | 11.445.000 | 5.198.000 | 2.516.000 |
| 西班牙 | 474.000 | 23.039.000 | 741.000 | 575.000 | 911.000 | 807.000 |
| 英國 | 2.982.000 | 7.120.000 | 1.008.000 | 5.120.000 | 3.544.000 | 4.401.000 |
| 比利時 | 5.337.000 | 5.474.000 | 252.000 | 809.000 | 10.457.000 | 1.082.000 |
| Others | 7.219.000 | 5.723.000 | 7.115.000 | 12.012.000 | 14.012.000 | 12.181.000 |
| Total | 115,664,000 | 96,792,000 | 100,303,000 | 110,119,000 | 153,315,000 | 95,224,000 |
圖形 - 以色列 - 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 全年 FOB USD
-and-similar-products/IL-WD/1064/2/1/Fob/DestinationCountry-Date/Israel-All-Exports-1064-Year.png)
圖形 - 以色列 - 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 全年 FOB USD
-and-similar-products/IL-WD/1064/2/1/Fob/DestinationCountry-Date/Israel-All-Exports-1064-Year.png)
表 - 以色列 - 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 全年 FOB USD
|
Date
Import Countries
|
2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 美國 | 141.878.000 | 78.362.000 | 76.932.000 | 106.470.000 | 188.354.000 | 83.827.000 |
| 巴西 | 5.819.000 | 4.974.000 | 6.156.000 | 24.594.000 | 21.133.000 | 15.241.000 |
| 比利時 | 16.618.000 | 26.708.000 | 16.281.000 | 5.264.000 | 3.313.000 | 6.000 |
| 俄羅斯 | 11.345.000 | 9.586.000 | 9.588.000 | 14.874.000 | 15.659.000 | 4.095.000 |
| 印度 | 6.443.000 | 10.532.000 | 8.420.000 | 12.443.000 | 14.710.000 | 1.195.000 |
| 德國 | 15.203.000 | 7.307.000 | 2.371.000 | 4.838.000 | 12.022.000 | 3.687.000 |
| 印尼 | 5.512.000 | 7.471.000 | 8.171.000 | 10.715.000 | 7.605.000 | 5.580.000 |
| 波蘭 | 4.335.000 | 5.538.000 | 8.266.000 | 7.110.000 | 7.270.000 | 3.002.000 |
| 阿根廷 | 4.510.000 | 5.937.000 | 5.506.000 | 4.437.000 | 8.559.000 | 4.517.000 |
| 土耳其 | 7.759.000 | 5.827.000 | 6.307.000 | 5.139.000 | 1.492.000 | |
| Others | 33.612.000 | 41.526.000 | 23.221.000 | 48.396.000 | 40.959.000 | 12.587.000 |
| Total | 253,034,000 | 203,768,000 | 171,219,000 | 244,280,000 | 321,076,000 | 133,737,000 |
圖形 - 以色列 - 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 每月 FOB USD
-and-similar-products/IL-WD/1064/2/4/Fob/DestinationCountry-Date/Israel-All-Exports-1064-Month.png)
圖形 - 以色列 - 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 每月 FOB USD
-and-similar-products/IL-WD/1064/2/4/Fob/DestinationCountry-Date/Israel-All-Exports-1064-Month.png)
表 - 以色列 - 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 每月 FOB USD
|
Date
Import Countries
|
11 - 2024 | 12 - 2024 | 01 - 2025 | 02 - 2025 | 03 - 2025 | 04 - 2025 |
|---|---|---|---|---|---|---|
| 美國 | 12.373.000 | 4.733.000 | 29.703.000 | 21.177.000 | 17.537.000 | 15.410.000 |
| 巴西 | 3.644.000 | 3.935.000 | 4.519.000 | 4.329.000 | 4.332.000 | 2.061.000 |
| 俄羅斯 | 1.797.000 | 2.999.000 | 697.000 | 579.000 | 1.589.000 | 1.230.000 |
| 德國 | 3.652.000 | 388.000 | 408.000 | 232.000 | 1.924.000 | 1.123.000 |
| 阿根廷 | 5.000 | 2.359.000 | 223.000 | 158.000 | 4.007.000 | 129.000 |
| 印尼 | 658.000 | 1.443.000 | 1.944.000 | 618.000 | 1.575.000 | |
| 印度 | 3.460.000 | 479.000 | 716.000 | |||
| 波蘭 | 1.246.000 | 49.000 | 320.000 | 1.553.000 | 150.000 | 979.000 |
| 義大利 | 365.000 | 272.000 | 666.000 | 676.000 | 718.000 | |
| 南非 | 422.000 | 412.000 | 361.000 | 563.000 | 661.000 | 194.000 |
| Others | 2.386.000 | 2.513.000 | 1.470.000 | 2.230.000 | 3.029.000 | 2.025.000 |
| Total | 30,008,000 | 17,660,000 | 39,810,000 | 33,441,000 | 34,326,000 | 26,160,000 |
圖形 - 以色列 - 進口 - 進化 / 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 全年 FOB USD
-and-similar-products/IL-IL/1064/3/1/Fob/-/Israel-Import-Export-1064-Year.png)
圖形 - 以色列 - 進口 - 進化 / 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 全年 FOB USD
-and-similar-products/IL-IL/1064/3/1/Fob/-/Israel-Import-Export-1064-Year.png)
表 - 以色列 - 進口 - 進化 / 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 全年 FOB USD
|
Date
Export Countries
|
2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Importaciones | ||||||
| 美國 | 264.342.000 | 291.527.000 | 234.718.000 | 247.581.000 | 226.287.000 | 103.022.000 |
| 德國 | 260.981.000 | 217.620.000 | 222.496.000 | 187.956.000 | 191.172.000 | 58.779.000 |
| 瑞士 | 154.639.000 | 164.702.000 | 177.509.000 | 214.948.000 | 216.323.000 | 69.844.000 |
| 愛爾蘭 | 157.487.000 | 174.306.000 | 164.613.000 | 176.312.000 | 167.029.000 | 53.256.000 |
| 比利時 | 106.783.000 | 428.635.000 | 157.806.000 | 47.253.000 | 64.545.000 | 12.600.000 |
| 西班牙 | 17.855.000 | 80.678.000 | 85.216.000 | 121.884.000 | 95.459.000 | 3.034.000 |
| 法國 | 48.316.000 | 70.762.000 | 48.035.000 | 64.318.000 | 74.003.000 | 32.136.000 |
| 荷蘭 | 24.570.000 | 28.223.000 | 30.211.000 | 59.344.000 | 65.779.000 | 44.482.000 |
| 義大利 | 23.471.000 | 34.779.000 | 30.615.000 | 52.141.000 | 48.410.000 | 22.415.000 |
| 英國 | 28.961.000 | 24.771.000 | 29.839.000 | 42.388.000 | 46.470.000 | 14.073.000 |
| Others | 51.248.000 | 110.541.000 | 195.754.000 | 106.918.000 | 118.843.000 | 45.320.000 |
| Total | 1,138,653,000 | 1,626,544,000 | 1,376,812,000 | 1,321,043,000 | 1,314,320,000 | 458,961,000 |
|
Date
Import Countries
|
2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Exportaciones | ||||||
| 美國 | 141.878.000 | 78.362.000 | 76.932.000 | 106.470.000 | 188.354.000 | 83.827.000 |
| 巴西 | 5.819.000 | 4.974.000 | 6.156.000 | 24.594.000 | 21.133.000 | 15.241.000 |
| 比利時 | 16.618.000 | 26.708.000 | 16.281.000 | 5.264.000 | 3.313.000 | 6.000 |
| 俄羅斯 | 11.345.000 | 9.586.000 | 9.588.000 | 14.874.000 | 15.659.000 | 4.095.000 |
| 印度 | 6.443.000 | 10.532.000 | 8.420.000 | 12.443.000 | 14.710.000 | 1.195.000 |
| 德國 | 15.203.000 | 7.307.000 | 2.371.000 | 4.838.000 | 12.022.000 | 3.687.000 |
| 印尼 | 5.512.000 | 7.471.000 | 8.171.000 | 10.715.000 | 7.605.000 | 5.580.000 |
| 波蘭 | 4.335.000 | 5.538.000 | 8.266.000 | 7.110.000 | 7.270.000 | 3.002.000 |
| 阿根廷 | 4.510.000 | 5.937.000 | 5.506.000 | 4.437.000 | 8.559.000 | 4.517.000 |
| 土耳其 | 7.759.000 | 5.827.000 | 6.307.000 | 5.139.000 | 1.492.000 | |
| Others | 33.612.000 | 41.526.000 | 23.221.000 | 48.396.000 | 40.959.000 | 12.587.000 |
| Total | 253,034,000 | 203,768,000 | 171,219,000 | 244,280,000 | 321,076,000 | 133,737,000 |
圖形 - 以色列 - 進口 - 進化 / 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 每月 FOB USD
-and-similar-products/IL-IL/1064/3/4/Fob/-/Israel-Import-Export-1064-Month.png)
圖形 - 以色列 - 進口 - 進化 / 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 每月 FOB USD
-and-similar-products/IL-IL/1064/3/4/Fob/-/Israel-Import-Export-1064-Month.png)
表 - 以色列 - 進口 - 進化 / 出口 - 進化 - NCE: 人体或动物制品 - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - 每月 FOB USD
|
Date
Export Countries
|
11 - 2024 | 12 - 2024 | 01 - 2025 | 02 - 2025 | 03 - 2025 | 04 - 2025 |
|---|---|---|---|---|---|---|
| Importaciones | ||||||
| 美國 | 19.743.000 | 10.439.000 | 26.785.000 | 28.388.000 | 30.119.000 | 17.730.000 |
| 瑞士 | 20.000.000 | 13.647.000 | 12.748.000 | 16.837.000 | 30.581.000 | 9.678.000 |
| 德國 | 23.354.000 | 8.540.000 | 13.826.000 | 17.277.000 | 17.277.000 | 10.399.000 |
| 愛爾蘭 | 24.337.000 | 2.700.000 | 28.126.000 | 6.090.000 | 5.408.000 | 13.632.000 |
| 荷蘭 | 3.556.000 | 2.210.000 | 1.533.000 | 2.363.000 | 21.984.000 | 18.602.000 |
| 法國 | 1.806.000 | 14.072.000 | 4.913.000 | 9.203.000 | 13.824.000 | 4.196.000 |
| 義大利 | 6.856.000 | 3.828.000 | 3.256.000 | 11.445.000 | 5.198.000 | 2.516.000 |
| 西班牙 | 474.000 | 23.039.000 | 741.000 | 575.000 | 911.000 | 807.000 |
| 英國 | 2.982.000 | 7.120.000 | 1.008.000 | 5.120.000 | 3.544.000 | 4.401.000 |
| 比利時 | 5.337.000 | 5.474.000 | 252.000 | 809.000 | 10.457.000 | 1.082.000 |
| Others | 7.219.000 | 5.723.000 | 7.115.000 | 12.012.000 | 14.012.000 | 12.181.000 |
| Total | 115,664,000 | 96,792,000 | 100,303,000 | 110,119,000 | 153,315,000 | 95,224,000 |
|
Date
Import Countries
|
11 - 2024 | 12 - 2024 | 01 - 2025 | 02 - 2025 | 03 - 2025 | 04 - 2025 |
|---|---|---|---|---|---|---|
| Exportaciones | ||||||
| 美國 | 12.373.000 | 4.733.000 | 29.703.000 | 21.177.000 | 17.537.000 | 15.410.000 |
| 巴西 | 3.644.000 | 3.935.000 | 4.519.000 | 4.329.000 | 4.332.000 | 2.061.000 |
| 俄羅斯 | 1.797.000 | 2.999.000 | 697.000 | 579.000 | 1.589.000 | 1.230.000 |
| 德國 | 3.652.000 | 388.000 | 408.000 | 232.000 | 1.924.000 | 1.123.000 |
| 阿根廷 | 5.000 | 2.359.000 | 223.000 | 158.000 | 4.007.000 | 129.000 |
| 印尼 | 658.000 | 1.443.000 | 1.944.000 | 618.000 | 1.575.000 | |
| 印度 | 3.460.000 | 479.000 | 716.000 | |||
| 波蘭 | 1.246.000 | 49.000 | 320.000 | 1.553.000 | 150.000 | 979.000 |
| 義大利 | 365.000 | 272.000 | 666.000 | 676.000 | 718.000 | |
| 南非 | 422.000 | 412.000 | 361.000 | 563.000 | 661.000 | 194.000 |
| Others | 2.386.000 | 2.513.000 | 1.470.000 | 2.230.000 | 3.029.000 | 2.025.000 |
| Total | 30,008,000 | 17,660,000 | 39,810,000 | 33,441,000 | 34,326,000 | 26,160,000 |
